The Primary Immunodeficiency or Primary Immune Deficiency Disease (PIDD) accounts for approximately 60% of Ig used for immunology patients and the growth of utilization year over year has been significant.
Highlights of our analysis demonstrate increasing annual dosage, prescriber variation and a steady increase in new and chronic patients, particularly in the sixth and seventh decade of life.
In 2016 the PIDD Working Group was formed in order to help establish a provincial framework for Ig use in PIDD. The Working Group representatives include: Dr. Doug Morrison (co-chair), Dr. Karen Dallas (co-chair), Dr. Bob Schellenberg, Dr. Donald Stark, Dr. Hein Reeves, Dr. Peter Lee, Dr. Kingsley Lee , Dr. Seung Kim, and Dr. Kyla Hildebrand.
The Working Group participated in the development of the Diagnostic and Treatment Algorithms as well as the PIDD Toolkit App.
| Algorithms | Dated |
| May 2018 | |
| May 2018 |
PIDD Toolkit
The PIDD Toolkit was created to provide timely access to standardized tools and resources in a central location. In addition to treatment and diagnostic algorithms, the application contains a dose calculator, a trough based dose adjustment calculator, links to the BC IG Recommendations and various references.
Partial funding support to develop the PIDD Toolkit application was provided by Canadian Blood Services BloodTechNet 2017 Learning Competition.
